Introducing Medray Softshock 2.0: Next-Generation Shockwave Therapy Has Arrived

Disclaimer:

The information provided in this educational material is intended solely for scientific and professional discussion among licensed healthcare practitioners. It is not promotional in nature and does not describe or imply any clinical benefit, therapeutic effect, or patient outcome. Medray Laser & Technology distributes Class I and Class II 510(k)-exempt devices. These devices do not require FDA premarket notification or FDA clearance. Any technical descriptions, operational principles, or modality overviews presented here are offered for scientific exchange only and do not constitute claims regarding safety, effectiveness, or clinical performance. References to physiological concepts, published literature, or general modality characteristics are provided to support professional understanding and do not establish or imply an indicated use for any specific medical condition. Healthcare professionals are responsible for determining appropriate use consistent with the device’s intended use, applicable regulations, and their clinical judgment. This content is not medical advice, does not guide patient care, and should not be used to make treatment decisions. Clinicians should rely on their training, professional expertise, and regulatory-compliant resources when evaluating any modality or device.